Superfund Research Program

Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure

Project Leader: Ronald M. Evans (Salk Institute for Biological Studies)
Co-Investigator: Michael Downes (Salk Institute for Biological Studies)
Grant Number: P42ES010337
Funding Period: 2017-2023

Project-Specific Links

Grant Recipient Patent List

Patents

• Chimeric Fibroblast Growth Factor (Fgf) 2/Fgf1 Peptides And Methods Of Use

  Number: 9,925,243
  Year: 2018
  Patent Status: Issued
  Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh, W. Kwiatkowski, S. Choe

• FGF2 Truncations and Methods of Use Thereof

  Number: 15/617,81
  Year: 2017
  Patent Status: Pending
  Authors: Atkins, A.R., M. Downes, R.M. Evans, R.T. Yu, J. Suh

• Increasing Storage of Vitamin A, Vitamin D, and/or Lipids

  Number: 15/984,146
  Year: 2018
  Patent Status: Pending
  Authors: Ding, N., M. Downes, R.M. Evans, M.H. Sherman

• Mutated Fibroblast Growth Factor (FGF) 1 and Methods of Use

  Number: 9,925,241
  Year: 2018
  Patent Status: Issued
  Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh

• Mutated Fibroblast Growth Factor (FGF) 1 and Methods of Use

  Number: 15/910,332
  Year: 2018
  Patent Status: Pending
  Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh